Phase 3 Trial Participation

The Side-Out Foundation is currently recruiting 100 patients for its Phase 3 clinical trial.

For more information on how you can participate in the Phase 3 study go to Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

Have more questions? Submit a request


Please sign in to leave a comment.